This, the first of our regional blogs, is authored by the technology and financial journalist Dominic Basulto. Dominic is a New York native, has been a senior editor at Corante since day one and has written for a number of online and offline media companies. Send tips or story ideas to: basulto@gmail.com.
About this weblog
Here we'll report daily on the latest tech and business developments in New York City. Impossible we concede: comprehensive coverage of the city's every story. What we hope you'll find: tips, tidbits and perspectives you won't find elsewhere. As well as unique insights, original interviews and more that should be of interest to New York's vibrant community of technologists and those who track, invest in and report on them.
Canadian regulators approve lung cancer drug Tarceva
Posted by Dominic Basulto
Good news for Long Island-based OSI Pharmaceuticals, with Canadian regulators giving their approval for Tarceva, the company’s lung-cancer drug. Tarceva, which OSI developed in partnership with Genentech, was approved in the United States last November, and is expected to be approved in Europe sometime soon.
TrackBack URL:
http://www.corante.com/cgi-bin/mt/external.cgi/31490